Diagnosis and treatment challenges in a rare Clostridium infection: A case report

Bianca Bălaș-Maftei1,2, Carmen-Elena Florea1,2, Maria Obreja2,3

  • 1Doctoral School, 'Grigore T. Popa' University of Medicine and Pharmacy, 00115 Iași, Romania.

Biomedical Reports
|September 9, 2024
PubMed

Insights

Clostridium paraputrificum bacteremia can cause severe septic shock. Carbapenem treatment showed promise as a first-line option for these challenging Gram-positive anaerobic infections.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases

Background:

  • The genus *Clostridium* comprises over 180 species of Gram-positive, anaerobic, sporulating bacteria.
  • Certain *Clostridium* species can cause severe invasive infections in humans.
  • *Clostridium paraputrificum* is a commensal bacterium of the intestinal flora.

Observation:

  • Bacteremia due to *C. paraputrificum* typically arises secondary to intestinal mucosal injury and in patients with predisposing conditions.
  • A case study involved a 70-year-old male with a history of alcohol consumption and cardiovascular disease.
  • Initial diagnoses including stroke, meningitis, and tetanus were ruled out before *C. paraputrificum* bacteremia was identified.

Findings:

  • The patient developed septic shock despite treatment with metronidazole and penicillin G.
  • Switching antibiotic therapy to carbapenem resulted in a favorable clinical outcome.
  • This suggests carbapenem may be an effective first-line treatment for *C. paraputrificum* infections.

Implications:

  • The findings suggest carbapenem as a potential first-line antibiotic for *Clostridium paraputrificum* infections.
  • This case highlights the importance of considering rare bacterial pathogens in severe sepsis.
  • Further research is warranted to establish optimal treatment guidelines for *C. paraputrificum* bacteremia.